Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC: A Phase I Clinical Trial()()

The maximum tolerated dose (MTD) of lobaplatin as a single agent chemotherapy concurrent with intensity-modulated radiotherapy (IMRT) in Asian population with nasopharyngeal carcinoma (NPC) remains unclear. From June 2016 to December 2017, 17 patients diagnosed with stage III-IVb NPC from an Asian p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Si-Yang, Xu, Xi-Wei, Yao, Ji-Jin, Peng, Pei-Jian, Zhou, Bin, Liu, Qiao-Dan, Huang, Xiao-Ping, Lin, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039884/
https://www.ncbi.nlm.nih.gov/pubmed/29966863
http://dx.doi.org/10.1016/j.tranon.2018.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039884/
https://www.ncbi.nlm.nih.gov/pubmed/29966863
http://dx.doi.org/10.1016/j.tranon.2018.06.004

Ejemplares similares